LISDEXAMFETAMINE DIMESYLATE
Generic: LISDEXAMFETAMINE DIMESYLATE
LISDEXAMFETAMINE DIMESYLATE is FDA application ANDA202827, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Failed Dissolution Specifications: An out of specification results observed in dissolution test duri
Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified co
Failed Dissolution Specifications: An out of specification results observed in dissolution test duri
Failed Dissolution Specifications: An out of specification results observed in dissolution test duri
Failed Dissolution Specifications: An out of specification results observed in dissolution test duri
Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Li
Failed Dissolution Specifications: An out of specification results observed in dissolution test duri
Failed Dissolution Specifications: An out of specification results observed in dissolution test duri
Failed Dissolution Specifications: An out of specification results observed in dissolution test duri
Failed Dissolution Specifications: An out of specification results observed in dissolution test duri